Skip to content
HowShorted

Cabaletta Bio, Inc. short interest in 2022

In 2022, Cabaletta Bio, Inc.'s disclosed short interest ran from 6.36% of shares outstanding on 14 Jan 2022 to 12.16% on 30 Dec 2022, a change of +5.80 percentage points. The year's high was 16.08% on 30 Sep 2022 and its low 6.13% on 14 Apr 2022, averaging 8.88% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.27 days on 28 Feb 2022. Full history: Cabaletta Bio, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Cabaletta Bio, Inc. in 2022

2022 in figures

Start of year
6.36% (14 Jan 2022)
End of year
12.16% (30 Dec 2022)
Change
+5.80 pp
High
16.08% (30 Sep 2022)
Low
6.13% (14 Apr 2022)
Average
8.88%
Highest days to cover
16.27 (28 Feb 2022)
SEC filings marked
8

Every report in 2022

Cabaletta Bio, Inc. short interest in 2022
SettlementShort interestDays to coverFilings since previous
14 Jan 20226.36%10.03
31 Jan 20226.28%13.25
15 Feb 20226.24%12.36
28 Feb 20226.26%16.27
15 Mar 20226.28%8.18
31 Mar 20226.28%7.9810-K filed, results (8-K)
14 Apr 20226.13%14.41
29 Apr 20226.14%8.09
13 May 20226.30%13.4610-Q filed, results (8-K)
31 May 20226.21%15.06
15 Jun 20226.33%10.56
30 Jun 20226.36%12.33
15 Jul 20226.75%10.29
29 Jul 20227.08%12.24
15 Aug 20227.66%4.5710-Q filed, results (8-K)
31 Aug 202211.85%1.00
15 Sep 202214.36%5.00
30 Sep 202216.08%7.98
14 Oct 202212.28%7.06
31 Oct 202212.99%1.03
15 Nov 202211.90%3.1910-Q filed, results (8-K)
30 Nov 202212.64%4.55
15 Dec 202212.21%3.82
30 Dec 202212.16%3.13

See also: Cabaletta Bio, Inc.'s full history · most shorted US stocks of 2022 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.